BERWYN, Pa.--(BUSINESS WIRE)--In recognition of October as National Breast Cancer Awareness Month, AscellaHealth, a specialty pharmacy benefit manager (SPBM), serving commercial, Medicare and Medicaid segments, highlights the importance of raising awareness for screening, early detection and improving treatment options for breast cancer. While these opportunities have helped to lower death rates from breast cancer in the past two decades, more can be done, with AscellaHealth taking a lead in providing members with clinical and educational programs to assist with their prescribed therapy.
“Beginning on day one, there is a critical need to help members with high deductible/co-insurance costs to utilize financial assistance programs and partner with physicians and pharmacists as they undergo the course of treatment,” says Dea Belazi, president and CEO, AscellaHealth. “We have the sensitivity to treating patients with breast cancer and offer a strategic approach to specialty pharmacy that is designed to improve outcomes and care coordination. Our high-touch model includes clinical interventions, adherence counseling, psychosocial assessment, integrated nursing staff, refill reminders and delivery coordination as part of AscellaHealth’s innovative specialty pharmacy strategy. These touch points really make the difference for each and every member.”
It is estimated that over 252,710 women in the United States will be diagnosed with breast cancer and more than 40,500 will die. On average, every two minutes a woman is diagnosed with breast cancer and one woman will die of breast cancer every 13 minutes. Of those with breast cancer, 64 percent end up paying $5,000 or more out of pocket over the course of their treatment in medical-related expenses.
AscellaHealth’s program is available on a standalone basis, or as part of a full-service pharmacy benefit management option that includes specialty drug management, formulary management services/rebates, competitive pricing and innovative discounting, drug utilization review, case management services/therapy management, clinical review/prior authorization, pharmacy and therapeutic management committee, flexible claims adjudication system, drug information and news reporting.
“This October we are doubling down on our commitment to helping health plan members battle breast cancer, making a difference in their lives while maximizing benefit plans,” Belazi adds. “By reducing costs, including discounted prices as part of the exceptional value we provide, our approach to specialty drugs can be a vital factor in breast cancer treatment.”
AscellaHealth, a specialty pharmacy benefit manager (SPBM), serving commercial, Medicare and Medicaid segments, offers high quality prescription drug benefit management services. Complemented by other customizable services, such as carved-out specialty pharmacy services and cost-savings programs, AscellaHealth provides a unique, proprietary service portfolio. Visit www.ascellahealth.com.